Analyst Ratings for Y-mAbs Therapeutics (YMAB) [Neutrals]

YMAB Rating Summary

YMAB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on YMAB
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $58.83 (+105%) * Over Last 12-Mos
Rating Score: 9.1 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/29/2020 Morgan Stanley
» Updated 11/12/2020
N/A New Coverage Equalweight
(N/A)
45.00
(42.00)
35.26
(28.70)
-18.6% Details
Like YMAB Ratings? Also take a look at TAK, LIZI, EOLS, IOVA

YMAB Ratings News